Villamor, Erlinda N.

HRN: 20-49-79  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/17/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/17/2022
11/23/2022
IV
600mg
Q8hrs
Aspiration Pneumonina
Waiting Final Action 
11/17/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/17/2022
11/23/2022
IV
4.5gram
Q8hrs
T/C Aspiration Pneumonia
Waiting Final Action 
11/25/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/25/2022
12/01/2022
IV
1.5g
Q8
Sepsis
Waiting Final Action 
11/27/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/27/2022
12/02/2022
IV
1.5gms
Q6
Empirical Escalation
Waiting Final Action 
11/28/2022
FLUCONAZOLE 50MG (CAP)
11/28/2022
12/04/2022
PO
50mg/cap
OD
Yeast Infection
Waiting Final Action 
11/29/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/29/2022
12/05/2022
IV
1.5g
Q6
Sepsis
Waiting Final Action 
12/01/2022
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
12/01/2022
12/07/2022
IV
500mg
OD
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: